ATE445630T1 - Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten - Google Patents

Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten

Info

Publication number
ATE445630T1
ATE445630T1 AT98920859T AT98920859T ATE445630T1 AT E445630 T1 ATE445630 T1 AT E445630T1 AT 98920859 T AT98920859 T AT 98920859T AT 98920859 T AT98920859 T AT 98920859T AT E445630 T1 ATE445630 T1 AT E445630T1
Authority
AT
Austria
Prior art keywords
rts
aslv
amv
rsv
producing
Prior art date
Application number
AT98920859T
Other languages
English (en)
Inventor
Gary Gerard
Michael Smith
Deb Chatterjee
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Application granted granted Critical
Publication of ATE445630T1 publication Critical patent/ATE445630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98920859T 1997-04-22 1998-04-22 Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten ATE445630T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4458997P 1997-04-22 1997-04-22
US4987497P 1997-06-17 1997-06-17
PCT/US1998/008072 WO1998047912A1 (en) 1997-04-22 1998-04-22 Methods for the production of aslv reverse transcriptases composed of multiple subunits

Publications (1)

Publication Number Publication Date
ATE445630T1 true ATE445630T1 (de) 2009-10-15

Family

ID=26721734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920859T ATE445630T1 (de) 1997-04-22 1998-04-22 Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten

Country Status (9)

Country Link
US (7) US6989259B2 (de)
EP (3) EP2251347A3 (de)
JP (1) JP2001523098A (de)
CN (1) CN1259957B (de)
AT (1) ATE445630T1 (de)
AU (1) AU7360198A (de)
CA (1) CA2287542A1 (de)
DE (1) DE69841241D1 (de)
WO (1) WO1998047912A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244797B1 (en) * 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
US5861295A (en) 1997-01-02 1999-01-19 Life Technologies, Inc. Nucleic acid-free thermostable enzymes and methods of production thereof
AU7100198A (en) 1997-04-03 1998-10-22 Life Technologies, Inc. Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
ATE445630T1 (de) 1997-04-22 2009-10-15 Life Technologies Corp Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten
US20040185493A1 (en) * 1997-05-12 2004-09-23 Invitrogen Corporation Methods for production and purification of nucleic acid molecules
NZ512244A (en) 1998-11-12 2003-12-19 Invitrogen Corp Polycationic transfection reagents for introducing anions into a cell
CA2363924A1 (en) 1999-03-02 2000-09-08 Invitrogen Corporation Compositions and methods for use in recombinational cloning of nucleic acids
US6630333B1 (en) 1999-03-23 2003-10-07 Invitrogen Corporation Substantially pure reverse transriptases and methods of production thereof
CA2374515A1 (en) * 1999-05-21 2000-11-30 Christian E. Gruber Compositions and methods for labeling of nucleic acid molecules
AU785483B2 (en) 1999-12-10 2007-09-20 Invitrogen Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
NZ520908A (en) 2000-03-15 2005-02-25 Invitrogen Corp High fidelity reverse transcriptases and uses thereof
US7078208B2 (en) * 2000-05-26 2006-07-18 Invitrogen Corporation Thermostable reverse transcriptases and uses thereof
EP1290149A4 (de) * 2000-05-26 2004-03-17 Invitrogen Corp Thermostabile reverse transkriptase und deren anwendungen
US9771565B2 (en) 2000-05-26 2017-09-26 Life Technologies Corporation Thermostable reverse transcriptases and uses thereof
US20060141632A1 (en) * 2000-07-25 2006-06-29 The Procter & Gamble Co. New methods and kits for sequencing polypeptides
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
DE10046960A1 (de) * 2000-09-22 2002-04-11 Roche Diagnostics Gmbh Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen
EP2105496B1 (de) 2000-12-08 2013-02-20 Life Technologies Corporation Verfahren und Zusammensetzungen zur Synthese von Nukleinsäuremolekülen unter Verwendung multipler Erkennungsstellen
US20030021799A1 (en) * 2001-07-11 2003-01-30 Wilkinson Jonathan Frome Reverse transcriptase formulations
US20070020622A1 (en) * 2001-09-14 2007-01-25 Invitrogen Corporation DNA Polymerases and mutants thereof
US20040152072A1 (en) * 2002-07-30 2004-08-05 Invitrogen Corporation Reverse transcription
EP1554377B1 (de) 2002-09-13 2012-11-07 Life Technologies Corporation Thermostabile reverse transkriptasen und deren anwendung
US7141398B2 (en) * 2002-12-30 2006-11-28 Rosetta Inpharmatics Llc Methods for recycling mRNA for linear cRNA amplification
US20040157213A1 (en) * 2003-01-27 2004-08-12 Kennell John C. Fungal reverse transcriptases with enhanced capabilities
EP1594982A4 (de) * 2003-01-29 2006-04-12 Quanta Biosciences Inc Verfahren und zusammensetzungen zum nachweis und zur quantifizierung von rna
US20040265870A1 (en) * 2003-04-09 2004-12-30 Invitrogen Corporation Methods of synthesizing and labeling nucleic acid molecules
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
EP1671128B1 (de) * 2003-09-12 2010-02-17 Life Technologies Corporation Anwendungen des Resonanzenergietransfers zwischen Terbium und GFP
DE602004027538D1 (de) 2003-12-01 2010-07-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
US7794996B2 (en) * 2004-01-13 2010-09-14 The Institute Of Biophysics, Chinese Academy Of Sciences Recombinant murine leukemia virus reverse transcriptases, the genes encoding and the method for expressing it
US7566532B1 (en) 2004-07-02 2009-07-28 Quest Diagnostics Investments Incorporated Methods for detecting retroviruses
US9505846B2 (en) 2005-01-28 2016-11-29 Life Technologies Corporation Multi-component inhibitors of nucleic acid polymerases
US20060234360A1 (en) * 2005-04-13 2006-10-19 Paola Branduardi Ascorbic acid production from D-glucose in yeast
US7836146B2 (en) * 2005-06-27 2010-11-16 Novarc L.L.C System and method for concurrently downloading digital content and recording to removable media
WO2008157688A2 (en) * 2007-06-19 2008-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
GB0806562D0 (en) 2008-04-10 2008-05-14 Fermentas Uab Production of nucleic acid
EP2208785A1 (de) 2009-01-15 2010-07-21 Newbiotechnic, S.A. Verfahren und Kits zum Erzeugen von miRNA- und smallRNA-Expressionsvektoren und ihre Anwendung zur Entwicklung von lentiviralen Expressionsbibliotheken
EP3502272A1 (de) 2010-06-21 2019-06-26 Life Technologies Corporation Zusammensetzungen, kits und verfahren zur synthese und/oder zum nachweis von nukleinsäuren
EP2582839B1 (de) 2010-06-21 2016-05-18 Life Technologies Corporation Zusammensetzungen, verfahren und kits zur synthese und amplifikation von nukleinsäuren mit rt
KR101818126B1 (ko) 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
EP2492279A1 (de) 2011-02-25 2012-08-29 Laboratorios Del. Dr. Esteve, S.A. Schnelles immunogenes Auswahlverfahren mittels Lentivirenanzeige
CA2842321C (en) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
JP2013126402A (ja) * 2011-12-19 2013-06-27 Tosoh Corp 逆転写酵素の製造方法
JP2013165669A (ja) * 2012-02-15 2013-08-29 Kyoto Univ 変異型逆転写酵素
AU2013225823A1 (en) 2012-02-29 2014-09-18 President And Fellows Of Harvard College Rapid antibiotic susceptibility testing
EP2698377A1 (de) 2012-08-17 2014-02-19 Laboratorios Del. Dr. Esteve, S.A. Verbessertes schnelles Immunogene Auswahlverfahren für HIV gp120 Varianten
DK2914743T3 (da) 2012-11-02 2019-10-14 Life Technologies Corp Udvinding, detektering og kvantificering af lille rna
EP2805769A1 (de) 2013-05-24 2014-11-26 European Molecular Biology Laboratory Verfahren zur nanoskaligen Einzelzellenanalyse
US9663770B2 (en) 2014-01-22 2017-05-30 Life Technologies Corporation Reverse transcriptases for use in high temperature nucleic acid synthesis
CN106572974B (zh) 2014-07-15 2021-04-23 生命技术公司 用于将分子有效递送到细胞的具有脂质聚集体的组合物和方法
EP3967768A1 (de) 2015-03-13 2022-03-16 Life Technologies Corporation Zusammensetzungen für erfassung, nachweis und quantifizierung von kleinen rna-molekülen
WO2017100177A1 (en) 2015-12-07 2017-06-15 Bio-Rad Laboratories, Inc. Dimeric reverse transcriptase
KR20160045656A (ko) 2016-04-11 2016-04-27 (주)바이오니아 열안정성이 증가된 역전사효소
KR20170016422A (ko) 2017-02-03 2017-02-13 (주)바이오니아 열안정성이 증가된 역전사효소
WO2019118978A1 (en) 2017-12-15 2019-06-20 Baylor College Of Medicine Methods and compositions for the amplification of mrna
CN113785053B (zh) * 2018-12-26 2024-07-12 深圳华大生命科学研究院 酶活性提高的逆转录酶及其应用
WO2022265965A1 (en) 2021-06-14 2022-12-22 10X Genomics, Inc. Reverse transcriptase variants for improved performance
WO2023114473A2 (en) 2021-12-16 2023-06-22 10X Genomics, Inc. Recombinant reverse transcriptase variants for improved performance

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US60618A (en) * 1866-12-18 Improvement in potato digger
US28447A (en) * 1860-05-29 Improvement in machines for picking curled hair
US32086A (en) * 1861-04-16 Wagon-lock
US198944A (en) * 1878-01-08 Improvement in apparatus for refining raw sugars
US90618A (en) * 1869-05-25 Improvement in pruning-imflement
US4663290A (en) 1982-01-21 1987-05-05 Molecular Genetics, Inc. Production of reverse transcriptase
US4748233A (en) 1982-03-23 1988-05-31 Bristol-Myers Company Alpha-interferon Gx-1
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4891319A (en) 1985-07-09 1990-01-02 Quadrant Bioresources Limited Protection of proteins and the like
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5693517A (en) 1987-06-17 1997-12-02 Roche Molecular Systems, Inc. Reagents and methods for coupled high temperature reverse transcription and polymerase chain reactions
US5618711A (en) 1986-08-22 1997-04-08 Hoffmann-La Roche Inc. Recombinant expression vectors and purification methods for Thermus thermophilus DNA polymerase
US5374553A (en) 1986-08-22 1994-12-20 Hoffmann-La Roche Inc. DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima
US5561058A (en) 1986-08-22 1996-10-01 Hoffmann-La Roche Inc. Methods for coupled high temperatures reverse transcription and polymerase chain reactions
US5407800A (en) 1986-08-22 1995-04-18 Hoffmann-La Roche Inc. Reverse transcription with Thermus thermophilus polymerase
US5310652A (en) 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US4962022A (en) 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
US5618702A (en) 1988-08-19 1997-04-08 City Of Hope PCR amplification of mRNA
SU1490961A1 (ru) 1987-06-17 1994-07-15 Институт Биохимии И Физиологии Микроорганизмов Ан Ссср Способ получения обратной транскриптазы вируса саркомы рауса
US5244797B1 (en) 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5498523A (en) 1988-07-12 1996-03-12 President And Fellows Of Harvard College DNA sequencing with pyrophosphatase
US5219989A (en) 1988-12-13 1993-06-15 Mcgill University Bifunctional protein for the isolation of capped mRNA
GB8903593D0 (en) 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
DE69131321T2 (de) 1990-09-28 1999-12-16 F. Hoffmann-La Roche Ag, Basel Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen
AU8906091A (en) 1990-10-05 1992-04-28 Wayne M. Barnes Thermostable dna polymerase
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
CZ291877B6 (cs) 1991-09-24 2003-06-18 Keygene N.V. Způsob amplifikace přinejmenším jednoho restrikčního fragmentu z výchozí DNA a způsob přípravy sestavy amplifikovaných restrikčních fragmentů
FR2690691B1 (fr) * 1992-04-29 1999-02-12 Bio Merieux Procede d'amplification d'arn necessitant une seule etape de manipulation.
US5436149A (en) 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
JPH0739378A (ja) 1993-07-30 1995-02-10 Takara Shuzo Co Ltd 逆転写酵素遺伝子
US5556772A (en) 1993-12-08 1996-09-17 Stratagene Polymerase compositions and uses thereof
US5512462A (en) 1994-02-25 1996-04-30 Hoffmann-La Roche Inc. Methods and reagents for the polymerase chain reaction amplification of long DNA sequences
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5912155A (en) 1994-09-30 1999-06-15 Life Technologies, Inc. Cloned DNA polymerases from Thermotoga neapolitana
JPH08131171A (ja) 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd 逆転写酵素の安定化組成物
US5556771A (en) 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
US5962271A (en) 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
US6013488A (en) 1996-07-25 2000-01-11 The Institute Of Physical And Chemical Research Method for reverse transcription
US6060240A (en) 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
AU7100198A (en) 1997-04-03 1998-10-22 Life Technologies, Inc. Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
ATE445630T1 (de) 1997-04-22 2009-10-15 Life Technologies Corp Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten
ATE205879T1 (de) 1997-05-13 2001-10-15 Azign Bioscience As Eine methode zum klonieren von mrna und darstellung von differentiell exprimierten transcripten (dodet)
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
US6630333B1 (en) * 1999-03-23 2003-10-07 Invitrogen Corporation Substantially pure reverse transriptases and methods of production thereof
US7078208B2 (en) 2000-05-26 2006-07-18 Invitrogen Corporation Thermostable reverse transcriptases and uses thereof
JP3925124B2 (ja) * 2000-09-20 2007-06-06 株式会社村田製作所 弾性表面波装置の製造方法

Also Published As

Publication number Publication date
US20030032086A1 (en) 2003-02-13
US20020081581A1 (en) 2002-06-27
DE69841241D1 (de) 2009-11-26
EP1005481B1 (de) 2009-10-14
US6518019B2 (en) 2003-02-11
EP1005481A1 (de) 2000-06-07
CA2287542A1 (en) 1998-10-29
CN1259957A (zh) 2000-07-12
US20030186270A1 (en) 2003-10-02
US7115406B2 (en) 2006-10-03
EP2251347A3 (de) 2011-02-23
EP1005481A4 (de) 2005-03-16
WO1998047912A1 (en) 1998-10-29
EP2184289A1 (de) 2010-05-12
CN1259957B (zh) 2012-08-22
US6835561B1 (en) 2004-12-28
US20070269878A1 (en) 2007-11-22
AU7360198A (en) 1998-11-13
US6989259B2 (en) 2006-01-24
US20110008770A1 (en) 2011-01-13
JP2001523098A (ja) 2001-11-20
EP2251347A2 (de) 2010-11-17
US20030198944A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
ATE445630T1 (de) Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten
ATE430801T1 (de) Von wd-40 abstammende peptide und ihre verwendung
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
WO2002002627A3 (en) Interferon-like protein zcyto21
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DE69434953D1 (de) Verfahren zur Herstellung einer cDNA Bank
DE68929045D1 (de) Verfahren zur herstellung und auswahl von peptiden mit spezifischen eigenschaften
DK1133565T3 (da) Generering af specifikke bindingspartnere til (poly)peptider, som der kodes for af genomiske DNA-fragmenter eller EST'er
ATE551423T1 (de) Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
ATE460429T1 (de) Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb
DE69941701D1 (de) Mutanten von flt3-l und ihre verwendungen
DE69838334D1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
EP1088890A3 (de) Rekombinante BPI Proteine, Verwendung der BPI-Proteine und Methoden Ihrer Herstellung
DE69735274D1 (de) Verfahren zur herstellung von rekombinanten viren
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
KR900018373A (ko) 재조합 바쿨로바이러스, 이 바이러스를 사용하는 일본 뇌염바이러스의 외포 단백질 및 그 단백질의 제조방법.
DE69333914D1 (de) Verfahren und zusammensetzungen zur kontrolle der übersetzung der hcv-proteine
DK0552240T3 (da) Ny metode til behandling af depression
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
ATE469170T1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
DK1501936T3 (da) Familie af cytokin-proteiner
DE69736158D1 (de) Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
AR016939A1 (es) Metodo para seleccionar una vid transgenica o componente de una vid que tiene una resistencia aumentada a la enfermedad de ''fanleaf'' y una celulade planta transformada con un vector de expresion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties